News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Flynn James E
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Granted 15,000 options to buy
@ $44.68, valued at
$670.2k
|
|
| 06/12/2023 |
4
| Flynn James E (10% Owner) has filed a Form 4 on CareMax, Inc.|
Txns:
| Granted 33,750 options to buy
@ $0 |
|
| 05/11/2023 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 8,300 options to buy
@ $5.09, valued at
$42.2k
|
|
| 12/30/2022 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Oncorus, Inc.|
Txns:
| Sold 24,757 shares
@ $0.25, valued at
$6.2k
Sold 6,096 shares
@ $0.25, valued at
$1.5k
Sold 63,107 shares
@ $0.26, valued at
$16.4k
Sold 63,108 shares
@ $0.26, valued at
$16.4k
Sold 15,538 shares
@ $0.26, valued at
$4k
Sold 61,826 shares
@ $0.27, valued at
$16.7k
Sold 15,220 shares
@ $0.27, valued at
$4.1k
|
|
| 12/27/2022 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Oncorus, Inc.|
Txns:
| Sold 3,692 shares
@ $0.28, valued at
$1k
Sold 3,693 shares
@ $0.28, valued at
$1k
Sold 909 shares
@ $0.28, valued at
$254.5
Sold 28,977 shares
@ $0.27, valued at
$7.8k
Sold 7,136 shares
@ $0.27, valued at
$1.9k
|
|
| 12/21/2022 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Oncorus, Inc.|
Txns:
| Sold 44,394 shares
@ $0.29, valued at
$12.9k
Sold 10,930 shares
@ $0.29, valued at
$3.2k
Sold 6,562 shares
@ $0.31, valued at
$2k
Sold 1,616 shares
@ $0.31, valued at
$501
Sold 6,144 shares
@ $0.3, valued at
$1.8k
Sold 6,143 shares
@ $0.3, valued at
$1.8k
Sold 1,513 shares
@ $0.3, valued at
$453.9 |
|
| 12/15/2022 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Oncorus, Inc.|
Txns:
| Sold 934 shares
@ $0.41, valued at
$382.9
Sold 933 shares
@ $0.41, valued at
$382.5
Sold 230 shares
@ $0.41, valued at
$94.3
Sold 3,828 shares
@ $0.38, valued at
$1.5k
Sold 3,829 shares
@ $0.38, valued at
$1.5k
Sold 943 shares
@ $0.38, valued at
$358.3
Sold 1,375 shares
@ $0.39, valued at
$536.3
Sold 339 shares
@ $0.39, valued at
$132.2 |
|
| 11/21/2022 |
4
| Flynn James E (10% Owner) has filed a Form 4 on CareMax, Inc.|
Txns:
| Granted 12,123 options to buy
@ $0 |
|
| 11/07/2022 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Bought 650,000 shares
@ $33.5, valued at
$21.8M
|
|
| 09/20/2022 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Bought 2,777,777 shares
@ $3.15, valued at
$8.7M
|
|
| 07/05/2022 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 1,889,509 options to buy
@ $1.1114, valued at
$2.1M
|
|
| 06/21/2022 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Granted 20,000 options to buy
@ $9.36, valued at
$187.2k
|
|
| 06/08/2022 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Sold 13,132 shares
@ $25.29, valued at
$332.1k
Sold 11,868 shares
@ $25.29, valued at
$300.1k
Sold 171 shares
@ $25.08, valued at
$4.3k
Sold 155 shares
@ $25.08, valued at
$3.9k
Sold 6,909 shares
@ $24.47, valued at
$169.1k
Sold 6,243 shares
@ $24.47, valued at
$152.8k
|
|
| 05/11/2022 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 8,300 options to buy
@ $2.92, valued at
$24.2k
|
|
| 05/10/2022 |
4
| Flynn James E (10% Owner) has filed a Form 4 on PepGen Inc.|
Txns:
| Converted 268,480 shares
@ $0
Bought 208,333 shares
@ $12, valued at
$2.5M
Converted 273,313 preferred shares
@ $0 |
|
| 11/16/2021 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Oncology Institute, Inc.|
Txns:
| Converted 40 shares
@ $0
Converted 85,113 shares
@ $0
Bought 50,000 options to buy
@ $1000, valued at
$50M
Disposed of 707,960 options to buy
@ $0
Disposed of 14,887 options to buy
@ $0
Converted 40 options to buy
@ $0
Converted 85,113 options to buy
@ $0
Acquired 3,177,543 options to buy
@ $11.5, valued at
$36.5M
Acquired 625,000 options to buy
@ $11.5, valued at
$7.2M
|
|
| 10/28/2021 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Xilio Therapeutics, Inc.|
Txns:
| Converted 756,472 shares
@ $0
Bought 387,500 shares
@ $16, valued at
$6.2M
Converted 7,186,489 preferred shares
@ $0 |
|
| 09/02/2021 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 1,800 shares
@ $0
Granted 7,022 options to buy
@ $16.66, valued at
$117k
|
|
| 08/09/2021 |
4
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (10% Owner) has filed a Form 4 on DA32 Life Science Tech Acquisition Corp.|
Txns:
| Disposed/sold 701,250 options to buy
@ $0 |
|
| 08/04/2021 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Converted 8,494,140 shares
@ $0
Converted 897,671 shares
@ $0
Converted 45,716,568 preferred shares
@ $0
Converted 13,011,988 preferred shares
@ $0
Converted 4,831,384 preferred shares
@ $0
Converted 2,417,628 options to buy
@ $0
Bought 300,000 options to buy
@ $17, valued at
$5.1M
|
|
| 08/03/2021 |
4
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (10% Owner) has filed a Form 4 on DA32 Life Science Tech Acquisition Corp.|
Txns:
| Bought 1,600,000 shares
@ $10, valued at
$16M
Granted 650,000 shares
@ $10, valued at
$6.5M
|
|
| 07/30/2021 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Granted 43,000 options to buy
@ $17, valued at
$731k
|
|
| 07/21/2021 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Bought 390,836 shares
@ $14, valued at
$5.5M
Bought 680,592 shares
@ $14, valued at
$9.5M
|
|
| 07/13/2021 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Sold 99,325 shares
@ $15.81, valued at
$1.6M
|
|
| 07/07/2021 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Mirum Pharmaceuticals, Inc.|
Txns:
| Sold 10,599 shares
@ $17.011, valued at
$180.3k
Sold 49,239 shares
@ $16.195, valued at
$797.4k
Sold 6,837 shares
@ $15.869, valued at
$108.5k
|
|
| 07/02/2021 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Bought 228,569 shares
@ $8.75, valued at
$2M
Bought 228,571 shares
@ $8.75, valued at
$2M
Bought 228,570 shares
@ $8.75, valued at
$2M
|
|
| 06/10/2021 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Deerfield Healthcare Technology Acquisitions Corp.|
Txns:
| Granted 9,600,000 shares
@ $10, valued at
$96M
Granted 400,000 shares
@ $10, valued at
$4M
Exercised 3,368,750 options to buy
@ $0
Exercised 50,000 options to buy
@ $0
Granted 2,916,667 options to buy
@ $11.5, valued at
$33.5M
Acquired 672,000 options to buy
@ $11.5, valued at
$7.7M
|
|
| 06/03/2021 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Singular Genomics Systems, Inc.|
Txns:
| Converted 6,457,723 shares
@ $0
Converted 577,148 shares
@ $17.6, valued at
$10.2M
Bought 450,000 shares
@ $22, valued at
$9.9M
Bought 1,050,000 shares
@ $22, valued at
$23.1M
Converted 6,457,723 preferred shares
@ $0
Converted convertible notes
@ $0 |
|
| 05/17/2021 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 8,300 options to buy
@ $10.34, valued at
$85.8k
|
|
| 05/04/2021 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Werewolf Therapeutics, Inc.|
Txns:
| Converted 1,752,787 shares
@ $0
Bought 800,000 shares
@ $16, valued at
$12.8M
Converted 15,195,094 preferred shares
@ $0 |
|
| 03/30/2021 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Converted 1,572,960 shares
@ $0
Converted 1,301,626 shares
@ $0
Converted 433,551 shares
@ $0
Bought 625,000 shares
@ $16, valued at
$10M
Converted 1,572,960 preferred shares
@ $0
Converted 1,301,626 preferred shares
@ $0
Converted 433,551 preferred shares
@ $0 |
|
| 02/18/2021 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Oncorus, Inc.|
Txns:
| Bought 133,558 shares
@ $19, valued at
$2.5M
Bought 32,884 shares
@ $19, valued at
$624.8k
|
|
| 02/09/2021 |
4
| Flynn James E (10% Owner) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Converted 1,717,033 shares
@ $0
Bought 665,000 shares
@ $17, valued at
$11.3M
Converted 1,717,033 preferred shares
@ $0 |
|
|
|
|